Cart
sales@molnova.com
Reversine
CAS No. 656820-32-5
Reversine( Reversine. )
Catalog No. M15499 CAS No. 656820-32-5
Reversine, a small synthetic purine analogue (2,6-disubstituted purine), is a potent inhibitior of Aurora A/B/C with IC50s of 150-500 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 150 | In Stock |
|
| 50MG | 212 | In Stock |
|
| 100MG | 372 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameReversine
-
NoteResearch use only, not for human use.
-
Brief DescriptionReversine, a small synthetic purine analogue (2,6-disubstituted purine), is a potent inhibitior of Aurora A/B/C with IC50s of 150-500 nM.
-
DescriptionReversine, a small synthetic purine analogue (2,6-disubstituted purine), is a potent inhibitior of Aurora A/B/C with IC50s of 150-500 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsReversine.
-
PathwayApoptosis
-
TargetAdenosine Receptor
-
RecptorA3| Aurora A| Aurora B| Aurora C
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number656820-32-5
-
Formula Weight393.49
-
Molecular FormulaC21H27N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 5 mg/mL warmed (12.71 mM)
-
SMILESC1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2[nH]cnc12
-
Chemical NameN6-cyclohexyl-N2-(4-morpholinophenyl)-7H-purine-2,6-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.D'Alise AM, et al. Mol Y Ther. 2008, 7(5), 1140-1149.
molnova catalog
related products
-
ZM-241385
ZM-241385 is a potent, non-xanthine A2A selective adenosine receptor antagonist with rat PC12 binding pIC50 of 9.52.
-
N6-Ethyladenosine
N6-Ethyladenosine is an adenosine derivative, acts as an agonist of Adenosine receptor(hA1AR and hA3AR with Kis of 4.9 and 4.7 nM , respectively).
-
Meranzin hydrate
Meranzin hydrate exhibits antidepressive and prokinetic-like effects through the regulation of the common mediator, the alpha 2-adrenoceptor , and α±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
